Xeris Biopharma files New Jersey patent suits after KEVEYIS patent grant
Xeris Biopharma filed patent infringement suits on Oct. 13, 2026 in New Jersey federal court tied to KEVEYIS (dichlorphenamide). Actions follow issuance of U.S. Patent No. 12,758,502 covering the product. Claims target proposed generic dichlorphenamide products, alleging infringement through making, selling, or importi